Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I

Lorenzo Lodi1,2, Isabelle Melki1,3,4, Vincent Bondet5

  • 1Université de Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, 24 boulevard du Montparnasse, 75015, Paris, France.

Insights

Type I interferonopathies (T1Is) involve elevated interferon signaling, but central nervous system (CNS) involvement varies. This study found distinct sites of IFN-alpha production in monogenic T1Is, differentiating CNS involvement in Aicardi-Goutières syndrome versus peripheral production in SAVI.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Rheumatology

Background:

  • Type I interferonopathies (T1Is) share upregulated type I interferon (IFN) signaling.
  • Central nervous system (CNS) involvement differs among T1Is, with unclear underlying mechanisms.
  • Understanding IFN production sites is crucial for diagnosing and treating T1Is.

Purpose of the Study:

  • To investigate the primary sites of IFN-alpha production in various T1Is.
  • To correlate IFN-alpha levels in cerebrospinal fluid (CSF) and serum with specific T1I diagnoses.
  • To elucidate the basis for variable CNS involvement in T1Is.

Main Methods:

  • Collected CSF and serum samples from patients with Aicardi-Goutières syndrome (AGS), STING-associated vasculopathy (SAVI), other monogenic T1Is (pT1I), neuropsychiatric lupus (nSLE), non-IFN autoinflammation (AI), and controls.
  • Quantified IFN-alpha protein levels using digital ELISA.
  • Compared IFN-alpha concentrations between CSF and serum within individuals and across disease groups.

Main Results:

  • Median CSF IFN-alpha levels were elevated in AGS, SAVI, pT1I, and nSLE compared to AI and controls.
  • AGS showed higher IFN-alpha levels in CSF than in paired serum.
  • SAVI, pT1I, and nSLE consistently had higher serum IFN-alpha levels compared to CSF.
  • IFN-alpha was detected in both CSF and serum across all studied IFN-related diseases.

Conclusions:

  • The primary site of IFN-alpha production in Aicardi-Goutières syndrome (AGS) is the CNS.
  • The primary site of IFN-alpha production in STING-associated vasculopathy (SAVI) is the periphery.
  • These findings differentiate monogenic T1Is and inform diagnostic and therapeutic strategies for T1Is.